Crescent Biopharma, a clinical-stage biotech company focused on cancer therapies, announced it will present at three investor conferences in November 2026: Guggenheim Healthcare Innovation, Stifel Healthcare, and Jefferies Global Healthcare. These presentations will include fireside chats and will be webcast live with replays available for 90 days. Crescent is advancing a pipeline including a PD-1 x VEGF bispecific antibody and antibody-drug conjugates, aiming to develop new cancer treatments. This visibility at key conferences may help attract investor interest as the company progresses clinical trials and reports data in early 2027.
Crescent Biopharma's upcoming presentations at investor conferences provide context for market participants. For readers following the health sector, here is Pluang's market snapshot as of Nov 02, 2026 19:21 WIB: of 150 priced health-sector US stocks, 82 rose and 47 fell today. Notable movers include MMED at USD 17.74 (-2.95%), MRVI at USD 8.03 (+2.82%), and BNGO at USD 1.18 (+2.61%).
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
